Clinical Trial Update: Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating tumor hypoxia and proliferation in high-grade glioma has been suspended. Sponsor: Weill Medical College of Cornell University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Glioma | Phase 1 | Status: SUSPENDED